Spots Global Cancer Trial Database for Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer
Official Title: Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer
Study ID: NCT04724031
Conditions
Interventions
Study Description
Brief Summary: Real-world clinical outcomes and toxicity data will be evaluated in patients with advanced high grade ovarian cancer who will receive PARP inhibitors.
Detailed Description: A prospective-retrospective analysis of patients with histologically confirmed high grade ovarian cancer who will receive or received olaparib or niraparib will be conducted at any line of treatment.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Adamantia Nikolaidi, Athens, Attiki, Greece
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
